Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of the American Academy of Dermatology
|
October 25, 2003
Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus
David Harden, Henry Skelton, Kathleen J Smith
Cutis
|
July 4, 2003
Teledermatology: an intraobserver diagnostic correlation study, Part II
Hon S Pak, David Harden, David Cruess, et al.
Cutis
|
May 29, 2003
Teledermatology: an intraobserver diagnostic correlation study, part I
Hon S Pak, David Harden, David Cruess, et al.
Journal of Biomolecular Screening
|
January 7, 2005
A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells
C David Weaver, David Harden, Steven I Dworetzky, et al.
ACS Medicinal Chemistry Letters
|
September 18, 2024
High-Throughput Assessment of Bile Salt Export Pump Inhibition Using RapidFire-MS and DESI-MS
Jie Li, Nicolás M Morato, Lori S Westover, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 14, 2020
Rapid Compound Integrity Assessment for High-Throughput Screening Hit Triaging
Wilson Z Shou, Samuel W Gerritz, David Harden, et al.
Plos One
|
June 10, 2016
A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses
Amy K Sheaffer, Min S Lee, Huilin Qi, et al.
Journal of Medicinal Chemistry
|
August 22, 2003
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition
Yong-Jin Wu, Carl D Davis, Steven Dworetzky, et al.
Science Translational Medicine
|
January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
Pancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of the American Academy of Dermatology
|
October 25, 2003
Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus
David Harden, Henry Skelton, Kathleen J Smith
Cutis
|
July 4, 2003
Teledermatology: an intraobserver diagnostic correlation study, Part II
Hon S Pak, David Harden, David Cruess, et al.
Cutis
|
May 29, 2003
Teledermatology: an intraobserver diagnostic correlation study, part I
Hon S Pak, David Harden, David Cruess, et al.
Journal of Biomolecular Screening
|
January 7, 2005
A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells
C David Weaver, David Harden, Steven I Dworetzky, et al.
ACS Medicinal Chemistry Letters
|
September 18, 2024
High-Throughput Assessment of Bile Salt Export Pump Inhibition Using RapidFire-MS and DESI-MS
Jie Li, Nicolás M Morato, Lori S Westover, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 14, 2020
Rapid Compound Integrity Assessment for High-Throughput Screening Hit Triaging
Wilson Z Shou, Samuel W Gerritz, David Harden, et al.
Plos One
|
June 10, 2016
A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses
Amy K Sheaffer, Min S Lee, Huilin Qi, et al.
Journal of Medicinal Chemistry
|
August 22, 2003
Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition
Yong-Jin Wu, Carl D Davis, Steven Dworetzky, et al.
Science Translational Medicine
|
January 6, 2017
Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding
Pancras C Wong, Dietmar Seiffert, J Eileen Bird, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Page
of 2